Vaccine Candidates for Type A Francisella tularesis

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Karl Klose

Funded by

US Dept of Defense

Research Start Date

06/01/2014

Status

Active

Collaborative Project

Basic Research

Drug Discovery

Infectious Disease

Bioscience Research Panel